<PAGE>
                                                                   Exhibit 10.17

THE WARRANTS AND THE COMMON SHARES DELIVERABLE UPON EXERCISE THEREOF HAVE NOT
BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "U.S.
SECURITIES ACT") OR UNDER ANY STATE SECURITIES LAWS. THESE WARRANTS AND THE
UNDERLYING COMMON SHARES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO
U.S. PERSONS UNLESS THESE WARRANTS AND THE UNDERLYING COMMON SHARES ARE
REGISTERED UNDER THE U.S. SECURITIES ACT, OR AN EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE U.S. SECURITIES ACT IS AVAILABLE. HEDGING TRANSACTIONS
INVOLVING THESE WARRANTS AND THE UNDERLYING COMMON SHARES MAY NOT BE CONDUCTED
UNLESS IN COMPLIANCE WITH THE U.S. SECURITIES ACT. THE HOLDER HEREOF, AGREES FOR
THE BENEFIT OF THE CORPORATION THAT THESE WARRANTS AND THE UNDERLYING COMMON
SHARES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE
CORPORATION, (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE U.S.
SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER OR ANOTHER APPLICABLE EXEMPTION,
OR (C) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT. DELIVERY OF THIS
CERTIFICATE MAY NOT CONSTITUTE "GOOD DELIVERY" IN SETTLEMENT OF TRANSACTIONS ON
STOCK EXCHANGES IN CANADA.

THIS WARRANT MAY NOT BE EXERCISED ON BEHALF OF ANY U.S. PERSON UNLESS REGISTERED
UNDER THE U.S. SECURITIES ACT OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE.

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST
NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS AND A DAY AFTER THE
LATER OF (i) _____________, AND (II) THE DATE THE ISSUER BECAME A REPORTING
ISSUER IN ANY PROVINCE OR TERRITORY.

ANY SHARE CERTIFICATE ISSUED PURSUANT TO AN EXERCISE OF THESE WARRANTS BEFORE
THE LATER OF (i) ____________, AND (II) THE DATE THE ISSUER BECAME A REPORTING
ISSUER IN ANY PROVINCE OR TERRITORY MUST CONTAIN THE FOLLOWING LEGEND:

         "UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS
         SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS
         AND A DAY AFTER THE LATER OF (i) ________, AND (II) THE DATE THE ISSUER
         BECAME A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY."

THE WARRANTS REPRESENTED HEREBY WILL BE VOID AND OF NO VALUE UNLESS EXERCISED
WITHIN THE TIME LIMIT HEREIN PROVIDED.

                 AGENT'S NON-TRANSFERABLE SHARE PURCHASE WARRANT

                          CHEMOKINE THERAPEUTICS CORP.
             (Incorporated under the laws of the State of Delaware)


No. 2004/_______               Representing _______ Share Purchase Warrants (the
                               "Warrants") entitling the Agent to purchase
                               _______ common shares, $0.001 par value.

THIS IS TO CERTIFY that, for value received, CANACCORD CAPITAL CORPORATION (the
"Agent"), of #2200 - 609 Granville Street, Vancouver, BC, V7Y 1H2,

<PAGE>

has the right to purchase from CHEMOKINE THERAPEUTICS CORP. (the "Company"),
upon and subject to the terms and conditions hereinafter referred to _______
fully paid and non-assessable common shares of the Company (the "Shares") at the
price of $____ per Share if exercised at any time until 4:30 p.m. (Vancouver
time) on _______, 2006 (the "Expiry Time").

THE FOLLOWING ARE THE TERMS AND CONDITIONS OF THE WARRANTS:

1.   The right to purchase Shares granted by this Warrant Certificate may only
     be exercised by the Agent within the times set out above by:

     (a)  completing and executing the Exercise Form attached to this Warrant
          Certificate in the manner indicated;

     (b)  surrendering this Warrant Certificate to Chemokine Therapeutics Corp.
          c/o Thomas, Rondeau, Suite 1525 - 625 Howe Street, Vancouver, B.C.,
          V6C 2T6; and

     (c)  paying the appropriate purchase price for the Shares subscribed for
          either by cash, certified cheque or bank draft payable at par in
          Vancouver, British Columbia.

2.   Upon surrender of this Warrant Certificate and receipt of payment, the
     Company will issue to the Agent the appropriate number of Shares issuable
     in accordance with the terms and conditions of this Warrant Certificate not
     exceeding those which the Agent is entitled to at the time of exercise. If
     the Agent exercises a portion of the Warrants represented by this Warrant
     Certificate, he or she will be entitled to receive, without charge, a new
     Warrant Certificate representing the unexercised portion of the Warrants
     represented herein.

3.   After the full or partial exercise by the Agent, the Company will cause to
     be mailed or delivered certificate(s) for the number of Shares issuable to
     the Agent within three business days at the address specified in the
     register of warrantholders maintained by the Company.

4.   The right to purchase Shares represented hereby has been issued by the
     Company in reliance upon the prospectus exemptions contained in applicable
     securities legislation. Consequently, any resale of the Shares by the Agent
     are subject to any applicable resale restrictions contained in such
     legislation.

5.   The Agent hereby agrees to comply with all applicable securities
     legislation in connection with the holding of the Warrants and the holding
     and exercise of the Shares issuable upon exercise of the Warrants.

6.   The Warrants evidenced by this Warrant Certificate are not transferable
     except where a person furnishes evidence that he is, to the reasonable
     satisfaction of the Company, a liquidator or, or a trustee in bankruptcy
     for, the Agent and surrenders such evidence together with the Warrant
     Certificate in question to the Company (by delivery or mail as set forth
     herein), and such further reasonable requirements as the Company and all
     applicable securities regulatory authorities may prescribe at which time
     such person will become noted upon the register of warrantholders. After
     receiving the surrendered

                                      -2-

<PAGE>


     Warrant Certificate and upon the Agent surrendering the Warrant Certificate
     meeting the requirements as hereinbefore set forth, the Company shall
     forthwith cause a new Warrant Certificate to be issued and sent to the new
     holder and the Company shall alter the register of warrantholders
     accordingly.

7.   Subject to the provisions of this Warrant Certificate and applicable law,
     the Agent is entitled to the rights and privileges attaching to the
     Warrants, and the issue of the Shares by the Company on exercise of
     Warrants by the Agent in accordance with the terms and conditions herein
     contained discharges all responsibilities of the Company with respect to
     such Warrants and the Company is not bound to inquire into the title of any
     such registered holder.

8.   Nothing in this Warrant Certificate or in the holding of Warrants evidenced
     by this Warrant Certificate, or otherwise, shall be construed as conferring
     upon the Agent any right or interest whatsoever as a shareholder, including
     but not limited to the right to vote at, to receive notice of, or to attend
     meetings of shareholders or any other proceedings of the Company or the
     right to receive any dividend and other distribution except as otherwise
     provided herein.

9.   The Company hereby covenants and agrees as follows:

     (a)  all Shares which may be issued upon exercise of this Warrant
          Certificate, in accordance with the respective terms thereof, will be
          validly issued, fully paid and non-assessable and free from any and
          all taxes, liens and charges with respect to the issue thereof (other
          than taxes in respect of any transfer occurring contemporaneously with
          such issue); and

     (b)  during the period within which the Warrants may be exercised, the
          Company will at all times have authorized and reserved a sufficient
          number of Shares to provide for the respective exercise of the
          Warrants.

10.  All Warrants in this series shall rank pari passu, notwithstanding the
     actual date of issue thereof.

11.  The Agent may at any time up to the Expiry Time, upon written instruction
     delivered to the Company and payment of applicable charges, exchange this
     Warrant Certificate for other Warrant Certificates evidencing Warrants
     entitling the Agent to acquire in the aggregate the same number of Shares
     as may be acquired under this Warrant Certificate.

12.  If any time after the date hereof and prior to the Expiry Time, and
     provided that any Warrants remain unexercised, there shall be:

     (a)  a reclassification of the Shares outstanding at the time or a change
          in the Shares into other shares or securities or a subdivision or
          consolidation of the Shares into a greater or lesser number of Shares,
          or any other capital reorganization; or

     (b)  a consolidation, amalgamation or merger of the Company with or into
          any other Company (other than a consolidation, amalgamation or merger
          which does not result in any reclassification of the outstanding
          common shares or a change of the common shares into other share or
          securities),

                                      -3-
<PAGE>

     (any of such events being call a "Capital Reorganization"), the Agent which
     thereafter shall exercise or be deemed to have exercised its right to
     acquire the Shares pursuant to this Warrant Certificate shall be entitled
     to receive, at no additional cost, and shall accept in lieu of the number
     of the Shares to which the Agent was theretofore entitled upon such
     exercise, the aggregate number of shares, warrants, other securities or
     other property which the Agent should have been entitled to receive as a
     result of such Capital Reorganization if, on the effective date or record
     date thereof as the case may be, the Agent had been the registered
     shareholder of the number of the Shares to which the Agent was theretofore
     entitled to acquire upon exercise or deemed exercise of this Warrant
     Certificate. If determined appropriate by the Company acting reasonably,
     appropriate adjustments shall be made as a result of any such Capital
     Reorganization in the application of the provisions set forth herein with
     respect to the rights and interests thereafter of the Agent to the end that
     the provisions set forth herein shall thereafter correspondingly be made
     applicable as nearly as may reasonably be in relation to any warrants,
     other securities or other property thereafter deliverable upon the exercise
     of any Warrants. Any such adjustment shall be made by and approved by the
     directors and shall for all purposes be conclusively deemed to be an
     appropriate adjustment.

13.  The adjustments provided for herein are cumulative and such adjustments
     shall be made successively whenever an event referred to herein shall
     occur, subject to the limitations provided for herein.

14.  No adjustments shall be made in the number or kind of Shares or other
     securities which may be acquired on the exercise of a Warrant unless it
     would result in a change of at least one-hundredth of a Share (provided,
     however, that any adjustments which may by reason of this paragraph not be
     required to be made, shall be carried forward and then taken into
     consideration in any subsequent adjustment).

15.  No adjustment shall be made in respect of any event described herein, if
     the Agent is entitled to participate in such event on the same terms,
     without amendment, as if the Agent had exercised his or her Warrants prior
     to or on the effective date or record date of such event.

16.  In the event of any question arising with respect to any adjustment
     provided for herein, such question shall be conclusively determined by a
     firm of chartered accountants appointed by the Company at its sole
     discretion (which may be the Company's auditors) and any such determination
     shall be binding upon the Company and the Agent.

17.  As a condition precedent to the taking of any action which would require
     any adjustments in any of the subscription rights pursuant to any of the
     Warrants, the Company shall take any corporate action which may, in the
     opinion of counsel of the Company, be necessary in order that the Company
     have unissued and reserved in its authorized capital and may validly and
     legally issue as fully paid and non-assessable all the securities which the
     Agent is entitled to receive on the exercise of all the subscription rights
     attaching thereto in accordance with the provisions thereof.

18.  In case the Company, after the date hereof, shall take any action affecting
     any securities of the Company, other than as previously set out herein,
     which in the opinion of the

                                      -4-
<PAGE>

     directors of the Company would materially affect the rights of the Agent,
     the number of Shares which shall be issuable on the exercise or deemed
     exercise of the Warrants shall be adjusted in such manner, if any, and at
     such time, as the directors, in their sole discretion, may determine to be
     equitable in the circumstances provided that no such adjustment will be
     made unless all necessary regulatory approvals, if any, have been obtained.
     Failure of the taking of action by the directors so as to provide for such
     an adjustment prior to the effective date of any action by the Company
     affecting any securities of the Company shall be evidence that the
     directors have determined that it is equitable to make no adjustments in
     the circumstances.

19.  Notwithstanding any adjustments provided for herein or otherwise, the
     Company shall not be required upon the exercise of any Warrants, to issue
     fractional Shares in satisfaction of its obligations hereunder and except
     as provided for herein, any fractions shall be eliminated. To the extent
     that the Agent would otherwise be entitled to acquire a fraction of a
     Share, such right may be exercised in respect of such fraction only in
     combination with other rights which in the aggregate entitle the Agent to
     acquire a whole number of Shares.

20.  In any situation where an event occurs which results in an increase in the
     number of Shares which may be issuable on the exercise or deemed exercise
     of the Warrants taking effect immediately after the record date for a
     specific event, if any Warrant is exercised after that record date and
     prior to completion of the event, the Company may postpone the issuance, to
     the Agent, of the Shares to which the Agent is entitled by reason of such
     adjustment, but such Shares shall be so issued and delivered to the Agent
     upon completion of that event, with the number of such Shares calculated on
     the basis of the number of Shares provided for after the adjustment
     provided for herein on the date of exercise of the Warrants adjusted for
     completion of that event and the Company shall deliver to the Agent an
     appropriate instrument evidencing the right of the Agent to receive such
     Shares and the right to receive any dividends or other distributions which,
     but for the provisions of this paragraph, such person or persons would have
     been entitled to receive in respect of such securities from and after the
     date that the Warrants were exercised in respect thereof.

21.  In case this Warrant Certificate shall become mutilated or be lost,
     destroyed or stolen, the Company, subject to applicable law, shall issue
     and deliver a new Warrant Certificate representing the Warrants of like
     date and tenor as the one mutilated, lost, destroyed or stolen upon
     surrender of and in place of and upon cancellation of the mutilated Warrant
     Certificate or in lieu of and in substitution for the lost, destroyed or
     stolen Warrant Certificate. The applicant for the issue of a new Warrant
     Certificate representing the Warrants pursuant to this section shall bear
     the cost of the issue thereof and in case of loss, destruction or theft
     shall, as a condition precedent to the issue thereof, furnish to the
     Company such evidence of ownership and of the loss, destruction or theft of
     the Warrant Certificate so lost, destroyed or stolen as shall be
     satisfactory to the Company and in its discretion and the applicant may
     also be required to furnish an indemnity in amount and form satisfactory to
     the Company in its discretion, and shall pay the reasonable charges of the
     Company in connection therewith.


                                      -5-

<PAGE>

22.  Any notice or delivery or surrender of documents shall be valid and
     effective if delivered personally or if sent by registered letter, postage
     prepaid, or if electronically transmitted by facsimile transmission tested
     for reception prior to use, addressed to:

     (a)  Chemokine Therapeutics Corp., c/o Thomas Rondeau, Suite 1525 - 625
          Howe Street, Vancouver, British Columbia, V6C 2T6, facsimile number
          (604) 688-6995; and

     (b)  to the Warrantholder at the address indicated on the first page,

     and shall be deemed to have been effectively given, received and made on
     the date of personal delivery or on the fourth Business Day after the time
     of mailing or upon actual receipt, whichever is sooner, or upon the day,
     other than Saturday, Sunday or a statutory holiday, after the time of
     facsimile transmission. In the case of disruption in postal services any
     notice, if mailed, shall not be deemed to have been effectively given until
     it is personally delivered. The Company or the Agent may from time to time
     notify the other in writing of a change of address.

23.  The Warrants represented by this certificate may be exercised in whole or
     in part from time to time, and this certificate may be exchanged, upon its
     surrender to the Company, for new Warrant Certificates of like tenor in
     denominations which represent in the aggregate the right to subscribe for
     and receive the number of Shares which may be subscribed for hereunder. If
     the Warrants represented by this certificate are exercised in part, the
     Company shall deliver with the Shares acquired on such exercise, a new
     Warrant Certificate representing the balance of the Warrants remaining
     unexercised.

24.  Unless the Warrants and Shares are registered under the U.S. Securities
     Act, the Agent exercising a Warrant shall be required to give (A) written
     certification that the Agent is not a U.S. person and the Warrant is not
     being exercised on behalf of a U.S. person; or (B) a written opinion of
     counsel to the effect that the Warrant and the securities delivered upon
     exercise thereof have been registered under the U.S. Securities Act or are
     exempt from registration thereunder. Further the Company may implement
     procedures to ensure that the Warrant may not be exercised within the
     United States, and that the Shares may not be delivered within the United
     States upon exercise, other than in offerings deemed to meet the definition
     of "offshore transaction" pursuant to Regulation S Section 230.902(h),
     unless registered under the U.S. Securities Act or an exemption from such
     registration is available.

25.  The Warrants and the Shares are deemed to be "restricted securities" as
     defined in SEC Rule Section 230.144. Resales of any of such restricted
     Warrants and Shares by a non-U.S. Person must be made in accordance with
     SEC Regulation S, the registration requirements of the U.S. Securities Act
     or an exemption therefrom. The Warrants and the Shares will continue to be
     deemed to be restricted securities, notwithstanding that they were acquired
     in a resale transaction made pursuant to SEC Regulation S Section 230.901
     or Section 230.904.

26.  Unless the Warrants and Shares are registered under the U.S. Securities
     Act, the offer or sale of the Warrant or the Shares by the Warrantholder,
     if made prior to the expiration of a one-year distribution compliance
     period (as defined in SEC Regulation S), is not made to a U.S. person or
     for the account or benefit of a U.S. person; and the offer or sale of the

                                      -6-
<PAGE>

     Warrant or the Shares by the Warrantholder, if made prior to the expiration
     of a one-year distribution compliance period (as defined in SEC Regulation
     S), is made pursuant to the following conditions: (1) The purchaser of the
     Warrant or the Shares certifies that it is not a U.S. person and is not
     acquiring the Warrant or the Shares for the account or benefit of any U.S.
     person or is a U.S. person who purchased the Warrant or the Shares in a
     transaction that did not require registration under the Act. (2) The
     purchaser of the Warrant or the Shares agrees to resell such securities
     only in accordance with the provisions of SEC Regulation S, pursuant to
     registration under the U.S. Securities Act, or pursuant to an available
     exemption from registration; and agrees not to engage in hedging
     transactions with regard to the Warrant or the Shares unless in compliance
     with the U.S. Securities Act

27.  Time shall be of the essence hereof.

28.  After the exercise of any of the Warrants represented by this Warrant
     Certificate, the Agent shall no longer have any rights under this Warrant
     Certificate with respect to such Warrants, other than the right to receive
     certificates representing the Shares issuable on the exercise of those
     Warrants, and those Warrants shall be void and of no further value or
     effect.

29.  This Warrant Certificate shall be construed in accordance with the laws of
     the Province of British Columbia and the laws of Canada applicable herein
     and shall be treated in all respects as a British Columbia contract.

IN WITNESS WHEREOF the Company has caused this Special Warrant certificate to be
signed by its duly authorized officer as of the ____ day of December, 2004.


CHEMOKINE THERAPEUTICS CORP.


Per:
          ---------------------------------------
          Authorized Signing Officer


Share Purchase Warrant No. 2004/___________


                                      -7-
<PAGE>


                                  EXERCISE FORM

TO:               CHEMOKINE THERAPEUTICS CORP.
                  c/o Thomas, Rondeau
                  Suite 1525 - 625 Howe Street
                  Vancouver, B.C.  V6C 2T6
--------------------------------------------------------------------------------

THE UNDERSIGNED Agent hereby exercises the right to acquire _____________ common
shares of CHEMOKINE THERAPEUTICS CORP., on the terms specified in the Warrant
Certificate.

The undersigned hereby directs that the said Shares be issued as follows:



<TABLE>
<CAPTION>

       NAME(S) IN FULL                    ADDRESS(ES)                          NUMBER OF SHARES
       ---------------                    -----------                          ----------------

<S>                             <C>                                <C>
-------------------------------  ---------------------------------  --------------------------------------

-------------------------------  ---------------------------------  --------------------------------------

</TABLE>

[Please print. If securities are issued to a person other than Agent, the Agent
must pay to the Company all eligible taxes and other duties and the signature of
the Agent must be guaranteed.]


DATED this ____ day of _____________________, ________________ .



----------------------------------       ----------------------------------
Signature Witnessed or                   (Signature of Agent to be the same
Guaranteed (See instructions             as appears on the face of this
to Agents below)                         Warrant Certificate)

Name of Agent:          ------------------------------------------------------

Address (PLEASE PRINT): ------------------------------------------------------

                        ------------------------------------------------------


Unless the Warrants and Shares are registered under the U.S. Securities Act the
Agent exercising a Warrant shall provide the following certification or include
an opinion of counsel to the effect that the Warrant and the securities
delivered upon exercise thereof have been registered under the U.S. Securities
Act or are exempt from registration thereunder.

The undersigned Agent hereby certifies that Agent is not a U.S. Person (as
defined in Regulation S under the U.S. Securities Act of 1933) and the Warrant
is not being exercised on behalf of a U.S. Person



                                            ---------------------------------
                                            (Signature of Agent)

<PAGE>


                              INSTRUCTIONS TO AGENT


TO EXERCISE:

If the Agent exercises Warrants prior to the Expiry Time pursuant to this
Warrant Certificate, it must deliver the Warrant Certificate and complete, sign
and deliver the Exercise Form to the Company indicating the number of Shares to
be acquired. In such case, the signature of such registered holder on the
Exercise Form must be witnessed or guaranteed, as the case may be.

If this exercise form indicates that the common shares and warrants are to be
issued to a person or persons other than the registered holder of this Warrant
Certificate, the signature of such holder on the exercise form must be
guaranteed by an authorized officer of a chartered bank, trust company or
Medallion Guaranteed by an investment dealer who is a member of a recognized
stock exchange.

GENERAL:

If the Exercise Form is signed by an officer of a corporation or any person
acting in a fiduciary or representative capacity, the Warrant Certificate must
also be accompanied by evidence of authority to sign satisfactory to the
Company.

The name and address of the Company is:

                          CHEMOKINE THERAPEUTICS CORP.
                               c/o Thomas, Rondeau
                          Suite 1525 - 625 Howe Street
                                 Vancouver, B.C.
                                     V6C 2T6